One Piece live-action writer Matt Owens has responded to Jamie Lee Curtis’ Instagram post lobbying for the role of Dr Kureha in Season 2 of the Netflix show, saying that they should talk once the Hollywood strikes come to an end.
Sharing a fan art of herself as Dr Kureha on Friday, the 64-year-old actress had mentioned that she will lobby for the role once the Hollywood strike against AMPTP is settled. “ONCE the STRIKE against the greed of the AMTPT is SETTLED with a FAIR CONTRACT, I will lobby along with the growing fan frenzy to become Doctor Kureha in @onepiecenetflix,” she wrote on the social media platform.
In response to her post, Owens, who is the showrunner alongside Steven Maeda, commented, “Mommy dearest, that’s why we sent you that figure! No need to lobby. Once we get what we deserve and get back to work let’s talk!”
Netflix’s One Piece live-action show is based on Eiichiro Oda’s ongoing manga of the same name. In the manga and its anime adaptation, Dr Kureha is one of the few doctors left in Drum Island who mentors Tony Tony Chopper, a reindeer with human abilities. With instructions from Dr Kureha, often referred to as a “witch-doctor” because of her appearance, Chopper gains medical skills and later joins the Straw Hat Pirates to fulfil his dream of becoming a great doctor capable of curing any illness.
Curtis later posted a clip from a media interview promoting her 2022 film Halloween Ends. During the conversation, the actress talked about how Tony Tony Chopper is one of her favourite characters from Oda’s manga and that her daughter Ruby Guest has encouraged her to play Dr Kureha in the second season of the live-action adaptation.
The actress, known for her roles in The Halloween (1978) and Knives Out (2019), had stated many times in the past that she is a massive fan of Oda’s works. She had also taken to social media earlier this year and jokingly asked Netflix for the role.
Directed by Matt Owens and Steven Maeda jointly and supervised by Oda himself, One Piece live-action series continues to be at No. 1 on Netflix’s top 10 global list since its debut on August 31.